Cancer and Alzheimer's will be "relics of the past" in less than a decade.
Dario Amoday makes this promise at the end of the roadshow video that Anthropic released today when it began offering its shares to investors.
"You know, if today we look at things like cancer, Alzheimer's, heart disease, mental illness, these will be relics of the past in, I think, less than a decade."
According to him, the company that accepts artificial intelligence risks will also be the one with the "operating license" that the company trusts.
"I think if we do it right, we can create an era of miracles where humanity is able to solve problems that have eluded us for thousands of years."
The stock price is expected on November 18, in the range of $70 to $78. Trading on the Nasdaq under ANT is scheduled to begin the next day.